# Allogeneic Versus Autologous Serum Eye Drops

> **NCT03085290** · NA · COMPLETED · sponsor: **Sanquin Research & Blood Bank Divisions** · enrollment: 18 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **OTHER:** Autologous serum eye drops
- **OTHER:** Allogeneic serum eye drops

## Key facts

- **NCT ID:** NCT03085290
- **Lead sponsor:** Sanquin Research & Blood Bank Divisions
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-26
- **Primary completion:** 2018-10-08
- **Final completion:** 2018-10-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03085290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03085290, "Allogeneic Versus Autologous Serum Eye Drops". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03085290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*